Nuvation Bio Inc. (NUVB)

Healthcare · Biotechnology · NYSE

Nuvation Bio Inc. (NUVB) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.14B and a free-cash-flow yield of -8.7%. Over the most recent reported fiscal year, revenue grew 699.0%.

Market cap	$2.14B
Trailing P/E	—
FCF yield	-8.7%
Revenue growth (YoY)	+699.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NYSE
Sector	Healthcare
Industry	Biotechnology

Explore live NUVB data on Nama Insights →